| Enero Group Limited (EGG) ORDINARY FULLY PAID |
Communication Services |
$43 |
Director Resignation and Appointment of CFO
|
19 Feb 2026 8:59AM |
$0.550 |
$0.475 |
fallen by
13.64%
|
|
| MA Financial Group Limited (MAF) ORDINARY FULLY PAID |
Financials |
$1,374 |
FY25 Results Presentation
|
19 Feb 2026 8:58AM |
$11.260 |
$7.010 |
fallen by
37.74%
|
|
MAF - Price-sensitive ASX Announcement
Full Release
Key Points
- Record Assets under Management of $15.3 billion, up 49% on FY24.
- Loan book grew 148% to $5.2 billion.
- Return on equity increased to 13.6% from 10.7% in FY24.
- Underlying revenue increased by 25% compared to FY24.
- Net profit after tax rose by 35% to $57.0 million.
- Finsure managed loans total $175 billion, showing a 26% increase.
- EBITDA increased by 30% to $113.0 million.
- Expenses increased by 23% to support growth and investments.
- Corporate Advisory revenue rose by 26% due to strong transaction flow.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MA Financial Group Limited (MAF) ORDINARY FULLY PAID |
Financials |
$1,374 |
MA Financial delivers FY25 financial result
|
19 Feb 2026 8:57AM |
$11.260 |
$7.010 |
fallen by
37.74%
|
|
MAF - Price-sensitive ASX Announcement
Full Release
Key Points
- MA Financial delivered a 35% increase in underlying net profit after tax (NPAT) in FY25.
- FY25 underlying NPAT was $57.0 million, and earnings per share (EPS) was 34.2 cents, both up significantly from FY24.
- The Board declared a fully franked final dividend of 14 cents per share, maintaining the FY25 total distribution at 20 cents per share.
- Assets under Management (AUM) grew by 49% to $15.3 billion, supported by acquisitions and strong inflows.
- MA Money's loan book increased by 148% to $5.2 billion with a net interest margin improvement.
- Corporate Advisory fees rose by 26% to $63 million as market conditions improved.
- MA Financial's revenue increased by 25% to $382.4 million, and underlying EBITDA grew by 30% to $113.0 million.
- MA Financial Group Limited operates in Asset Management, Lending & Technology, and Corporate Advisory & Equities.
- Strategic investments are set to slow, with a focus on maintaining growth and scaling MA Money.
- The Group's underlying revenue and earnings are anticipated to increase significantly in FY26.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WAM Microcap Limited (WMI) ORDINARY FULLY PAID |
Financials |
$429 |
Increased FF interim div, strong total shareholder return
|
19 Feb 2026 8:56AM |
$1.610 |
$1.530 |
fallen by
4.97%
|
|
WMI - Price-sensitive ASX Announcement
Full Release
Key Points
- WAM Microcap Limited declared an increased fully franked interim dividend of 5.35 cents per share.
- The annualised fully franked interim dividend yield is 6.6%, with a grossed-up yield of 9.4%.
- Total shareholder return (TSR) was 14.6% for six months to 31 December 2025, 16.2% including franking credits.
- Investment portfolio increased by 11.4% in six months to 31 December 2025.
- The S&P/ASX Small Ordinaries Accumulation Index rose 17.4%, driven by a shift towards resources and financials.
- WAM Microcap's investment portfolio has outperformed the benchmark by 8.3% per annum since inception.
- The portfolio reported an operating profit before tax of $43.2 million and after tax of $31.0 million for six months to 31 December 2025.
- WAM Microcap provides investors access to undervalued micro-cap growth companies with market capitalization under $300 million.
- The Dividend Reinvestment Plan (DRP) offers a 2.5% discount for the fully franked interim dividend.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Autosports Group Limited (ASG) ORDINARY FULLY PAID |
Consumer Discretionary |
$515 |
H1 FY26 Results Investor Presentation
|
19 Feb 2026 8:56AM |
$3.470 |
$2.500 |
fallen by
27.95%
|
|
ASG - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 10.9% to $1.519 billion.
- Gross margin improved to 19.1%.
- Normalized PBT increased by 75% to $35.3 million.
- Significant acquisitions in Canberra and Melbourne.
- Continued focus on luxury brand portfolio.
- Expect further growth through acquisitions and expansions.
- Service and parts revenue showed strong growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Downer EDI Limited (DOW) ORDINARY FULLY PAID |
Industrials |
$5,142 |
HY26 Results Presentation
|
19 Feb 2026 8:56AM |
$7.730 |
$7.770 |
risen by
0.52%
|
|
DOW - Price-sensitive ASX Announcement
Full Release
Key Points
- Statutory NPAT grew 29.8% to $98.0m.
- Revenue decreased by 10.7% to $4,918.8m.
- Focused on portfolio simplification and divestments.
- Strengthened balance sheet with net debt to EBITDA improving to 0.8x.
- Interim dividend increased by 19.4% to 12.9cps.
- Strategic focus on defence, energy, and utilities.
- Investment in transformation and technology for efficiency.
- Targeting a 6% EBITA margin by FY30.
- Over 90% cash conversion rate achieved.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Universal Store Holdings Limited (UNI) ORDINARY FULLY PAID |
Consumer Discretionary |
$569 |
H1 FY26 Results Presentation
|
19 Feb 2026 8:55AM |
$8.390 |
$7.410 |
fallen by
11.68%
|
|
UNI - Price-sensitive ASX Announcement
Full Release
Key Points
- Total sales increased by 14.2% to $209.6 million.
- LFL sales growth of 8.7% for Universal Store and 14.8% for Perfect Stranger.
- Gross profit margin improved by 150 basis points to 62.1%.
- Eight new stores opened, total store count at 118.
- Strong cash position with $38.4 million and no borrowings.
- Underlying EBIT increased by 23.2% to $43.6 million.
- Fully franked interim dividend raised by 18.1% to 26.0 cents per share.
- Increased costs due to wage inflation and team investments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dyno Nobel Limited (DNL) ORDINARY FULLY PAID |
Materials |
$5,639 |
Update - Notification of buy-back - DNL
|
19 Feb 2026 8:55AM |
$3.310 |
$3.200 |
fallen by
3.32%
|
|
| MA Financial Group Limited (MAF) ORDINARY FULLY PAID |
Financials |
$1,374 |
Dividend/Distribution - MAF
|
19 Feb 2026 8:55AM |
$11.260 |
$7.010 |
fallen by
37.74%
|
|
| Medical Developments International Limited (MVP) ORDINARY FULLY PAID |
Health Care |
$46 |
FY26 Half Year Announcement
|
19 Feb 2026 8:55AM |
$0.455 |
$0.410 |
fallen by
9.89%
|
|
MVP - Price-sensitive ASX Announcement
Full Release
Key Points
- Positive cashflow from operating activities for FY26 half year.
- Penthrox revenue up by $2.3 million.
- Penthrox volume growth of 26% in the Australian hospital segment.
- Penthrox European volume growth of 10%.
- Expanded PBS Prescriber Bag eligibility to Nurse Practitioners in Australia.
- MAGPIE paediatric study published, supporting Penthrox's paediatric use.
- Health economic study completed demonstrating cost savings with Penthrox.
- Cash balance as of 31 December 2025 was $16.9 million.
- Net loss after tax was $0.2 million for the half year.
- Continued focus on expanding Penthrox's market and regulatory approvals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MA Financial Group Limited (MAF) ORDINARY FULLY PAID |
Financials |
$1,374 |
FY25 Annual Report
|
19 Feb 2026 8:54AM |
$11.260 |
$7.010 |
fallen by
37.74%
|
|
| Medical Developments International Limited (MVP) ORDINARY FULLY PAID |
Health Care |
$46 |
FY26 Half Year Presentation
|
19 Feb 2026 8:54AM |
$0.455 |
$0.410 |
fallen by
9.89%
|
|
MVP - Price-sensitive ASX Announcement
Full Release
Key Points
- Penthrox® volume growth of 26% in Australian hospitals.
- Underlying demand for Penthrox® in Europe up 10%.
- MAGPIE paediatric study strengthens clinical evidence.
- Paediatric label approvals in Europe progressing.
- Health economic study shows cost savings with Penthrox®.
- Operating cash flow improved by $1.0 million.
- Strong balance sheet with $16.9 million cash as of December 2025.
- Group revenue increased by 8% to $21.6 million.
- Pain Management segment revenue up 18%.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Medical Developments International Limited (MVP) ORDINARY FULLY PAID |
Health Care |
$46 |
FY26 Half Year Report (including Appendix 4D)
|
19 Feb 2026 8:54AM |
$0.455 |
$0.410 |
fallen by
9.89%
|
|
MVP - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash flows generated from operating activities was $0.3 million.
- Payments for property, plant and equipment totaled $0.2 million.
- Revenue in the Pain Management segment increased by 18% to $15.4 million.
- Underlying EBIT was a $0.3 million loss, compared to a $0.2 million profit the previous period.
- The Respiratory segment revenue decreased by 10% to $6.2 million.
- Net loss after tax was $0.2 million.
- Net assets decreased slightly to $54.8 million from $55.1 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MA Financial Group Limited (MAF) ORDINARY FULLY PAID |
Financials |
$1,374 |
Appendix 4E
|
19 Feb 2026 8:52AM |
$11.260 |
$7.010 |
fallen by
37.74%
|
|
MAF - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue from ordinary activities increased by 36.1% to $1,219.9 million.
- Net profit after tax decreased by 75.1% to $10.4 million.
- Total comprehensive income fell by 62.1%.
- Interim dividend of 6 cents per share was paid on 24 September 2025.
- Proposed final dividend of 14 cents per share.
- Net tangible assets per ordinary share decreased to $1.42.
- Additional disclosures in the annual and directors' reports for 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Invion Limited (IVX) ORDINARY FULLY PAID |
Health Care |
$7 |
Notification regarding unquoted securities - IVX
|
19 Feb 2026 8:52AM |
$0.085 |
$0.070 |
fallen by
17.65%
|
|
| EROAD Limited (ERD) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Information Technology |
$139 |
Capital Change Notice - Issue of Performance Share Rights
|
19 Feb 2026 8:52AM |
$0.765 |
$0.740 |
fallen by
3.27%
|
|
| 88 Energy Limited (88E) ORDINARY FULLY PAID |
Energy |
$30 |
South Prudhoe Prospective Resource Update
|
19 Feb 2026 8:52AM |
$0.021 |
$0.026 |
risen by
23.81%
|
|
88E - Price-sensitive ASX Announcement
Full Release
Key Points
- 88 Energy Limited's South Prudhoe acreage is strategically located south of two of North America's largest oil fields.
- The prospective resource assessment identifies significant multi-zone, multi-million-barrel potential.
- South Prudhoe offers low-risk potential for fast-track development through existing infrastructure.
- Ivishak and Kuparuk prospects are adjacent to major oil fields, enhancing development prospects.
- 88 Energy has expanded its lease area through successful bidding, totaling approximately 52,269 acres.
- The net economic interest for 88 Energy has been calculated at 83.33%, and resources have been adjusted accordingly.
- Competent Person statements affirm the validity of the resource estimates.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Downer EDI Limited (DOW) ORDINARY FULLY PAID |
Industrials |
$5,142 |
HY26 Results Media Release
|
19 Feb 2026 8:51AM |
$7.730 |
$7.770 |
risen by
0.52%
|
|
DOW - Price-sensitive ASX Announcement
Full Release
Key Points
- EBITA margin increased to 4.6%, exceeding the management target.
- Statutory NPAT rose by 29.8% to $98 million.
- Underlying NPATA grew by 7% to $136.1 million.
- Underlying EBITA increased by 11.2% to $227.1 million.
- Downer continues its portfolio simplification strategy.
- Revenue slightly declined but work-in-hand increased by 8.9%.
- Declared a fully franked interim dividend of 12.9 cps.
- Focus remains on enhancing margins and contract performance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Enero Group Limited (EGG) ORDINARY FULLY PAID |
Communication Services |
$43 |
Half Year Results Investor Presentation
|
19 Feb 2026 8:51AM |
$0.550 |
$0.475 |
fallen by
13.64%
|
|
EGG - Price-sensitive ASX Announcement
Full Release
Key Points
- Enero Group reported a 119% increase in adjusted net profit and EPS for FY26 H1.
- EBITDA grew by 15% and the group saw a reduction in net finance costs.
- An interim dividend of 1.0 cps fully franked was declared with a payout ratio of 39% on adjusted EPS.
- THC Practice showed a 3% growth in EBITDA driven by strong performance in Australian agencies.
- Corporate costs reduced by 22% year-over-year, contributing to an improved EBITDA margin of 10.8%.
- Net cash flow decreased due to contingent consideration payments and restructuring costs.
- Revenue showed a slight decline by 1% due to challenging conditions in the international technology market.
- Enero Group is targeting dividend payments consistent with historical payout ratios of 30% - 50% of adjusted earnings per share.
- Significant effort in cost management and operational excellence helped mitigate revenue decline.
- Orchard and BMF showed strong performance with significant EBITDA and margin improvements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Universal Store Holdings Limited (UNI) ORDINARY FULLY PAID |
Consumer Discretionary |
$569 |
H1 FY26 Results Announcement
|
19 Feb 2026 8:51AM |
$8.390 |
$7.410 |
fallen by
11.68%
|
|
UNI - Price-sensitive ASX Announcement
Full Release
Key Points
- Group sales increased by 14.2% to $209.6 million.
- Gross profit margin expanded by 150 basis points to 62.1%.
- Underlying EBIT grew by 23.2% to $43.6 million.
- Statutory NPAT increased by 150.4% to $28.3 million.
- Declared a fully franked interim dividend of 26.0 cents per share.
- Operated 118 stores as of 31 December 2025.
- Focus on trendy, quality products and customer experience.
- Investments in team and technology for future growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tivan Limited (TVN) ORDINARY FULLY PAID |
Materials |
$692 |
Tivan ANU REECON Presentation
|
19 Feb 2026 8:51AM |
$0.470 |
$0.305 |
fallen by
35.11%
|
|
| MoneyMe Limited (MME) ORDINARY FULLY PAID |
Financials |
$67 |
1H26 Results Investor Presentation
|
19 Feb 2026 8:50AM |
$0.105 |
$0.083 |
fallen by
20.95%
|
|
MME - Price-sensitive ASX Announcement
Full Release
Key Points
- 17% increase in gross revenue to $117 million
- 26% increase in loan book to $1.75 billion
- Statutory NPAT loss improved by 44% to $21.9 million
- Normalized NPAT loss improved to $4.6 million
- Operating cash profit of $9.9 million excluding one-off benefits
- Expanded Autopay and personal loan products with focus on secured lending
- Net credit loss rate reduced to 2.9%
- Achieved Certified B Impact Assessment score of 91.2
- Strengthened data security and ESG initiatives
- Plans for new credit card launch and technology platform enhancements
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sonic Healthcare Limited (SHL) ORDINARY FULLY PAID |
Health Care |
$9,875 |
CEO Presentation Half Year Results to 31 December 2025
|
19 Feb 2026 8:50AM |
$21.240 |
$19.980 |
fallen by
5.93%
|
|
SHL - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue growth of 17% to A$5.445 billion.
- Net profit increased by 11% to A$262 million.
- EPS improved by 8%.
- EBITDA guidance for FY 2026 maintained.
- Strong performance in Germany and UK markets.
- Ongoing integration and restructuring in the US.
- Focus on capital management and operational efficiency.
- Interim dividend declared at $0.45, 60% franked.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Enero Group Limited (EGG) ORDINARY FULLY PAID |
Communication Services |
$43 |
Half Year Results Announcement
|
19 Feb 2026 8:49AM |
$0.550 |
$0.475 |
fallen by
13.64%
|
|
EGG - Price-sensitive ASX Announcement
Full Release
Key Points
- Enero Group Limited reported a 15% increase in EBITDA for FY26 H1.
- Net profit and earnings per share rose by 119% compared to FY25 H1.
- Net revenue decreased by 1% due to international technology market challenges.
- EBITDA margins improved from 9.3% to 10.8% through cost management.
- BMF and Orchard reported strong performances with significant EBITDA growth.
- Interim dividend declared at 1.0 cent per share, fully franked.
- Net cash on balance sheet at $23.6 million as of December 31, 2025.
- Strategic leadership changes, including new CEO appointments at Hotwire.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sonic Healthcare Limited (SHL) ORDINARY FULLY PAID |
Health Care |
$9,875 |
Media Release Half Year Results to 31 December 2025
|
19 Feb 2026 8:49AM |
$21.240 |
$19.980 |
fallen by
5.93%
|
|
SHL - Price-sensitive ASX Announcement
Full Release
Key Points
- Sonic Healthcare's revenue increased by 17% to A$5,445 million.
- Net profit rose by 11% to A$262 million.
- EBITDA grew by 10% to A$907 million.
- Maintained full-year FY 2026 earnings guidance.
- Ongoing review and restructuring in the US operations.
- Strong performance in Germany and Switzerland.
- Integration of recent acquisitions progressing well.
- Progressive dividend policy with a 1 cent increase.
- Continued focus on cost control and operational efficiency.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
